KLRS

Kalaris Therapeutics
KLRS

Overview Fund Trends Analyst Outlook Journalist POV

84 hedge funds and large institutions have $110M invested in Kalaris Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership: →

more funds holding

Funds holding: →

40% less capital invested

Capital invested by funds: $184M → $110M (-$74.5M)

Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$129K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.8M
2
+$2.94M
3
+$970K
4
BlackRock
BlackRock
New York
+$966K
5
State Street
State Street
Massachusetts
+$566K

Top Sellers

1
-$9.72M
2
-$2.92M
3
-$2.46M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$922K
5
Citadel Advisors
Citadel Advisors
Florida
-$736K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$9K
77
$8K
78
$4K
79
$4K
80
$3K
81
$3K
82
$2K
83
$1K
84
$1K
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
1 2 3
4